Achieve Life Sciences, Inc. earnings per share and revenue
On Nov 06, 2025, ACHV reported earnings of -0.28 USD per share (EPS) for Q3 25, missing the estimate of -0.26 USD, resulting in a -6.75% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.85% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analysts forecast an EPS of -0.27 USD, with revenue projected to reach -- USD, implying an decrease of -3.57% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were Achieve Life Sciences, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Achieve Life Sciences, Inc. reported EPS of -$0.28, missing estimates by -6.75%, and revenue of $0.00, 0% as expectations.
How did the market react to Achieve Life Sciences, Inc.'s Q3 2025 earnings?
The stock price moved down -3.85%, changed from $4.93 before the earnings release to $4.74 the day after.
When is Achieve Life Sciences, Inc. expected to report next?
The next earning report is scheduled for Mar 09, 2026.
What are the forecasts for Achieve Life Sciences, Inc.'s next earnings report?
Based on 9
analysts, Achieve Life Sciences, Inc. is expected to report EPS of -$0.27 and revenue of -- for Q4 2025.